There are many challenges faced by the biopharmaceutical industry in order to develop and provide sufficient drugs to treat a growing and ageing population. This article discusses whether continuous processing provides the solution.
List view / Grid view
Dr John Milne (National Institute for Bioprocessing Research and Training)
Filter the results